Yaqian Shi

447 citations
28 papers · 274 indexed · h-index 12
Topics
Systemic Sclerosis and Related Diseases (15 papers)Dermatologic Treatments and Research (6 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers)
Partner nations
ChinaJapanCanada

In The Last Decade

Yaqian Shi

25 papers receiving 269 citations

Peers

Yaqian Shi
Comparison fields: 5 of 64
  • Pathology and Forensic Medicine 87
  • Dermatology 74
  • Immunology 70
  • Cell Biology 67
  • Molecular Biology 60
Replace Richard Azurdia with:
Richard Azurdia United Kingdom
Sabrina Nurmohamed Canada
Shijun Shan China
Ni Lian China
Qiaofang Yi United States
Sumika Toyama Japan
Liteng Yang China
Mi Kyeong Kim South Korea
Erfei Chen China
Zia U.A. Mollah Japan
Yaqian Shi relative to Richard Azurdia United Kingdom Richard Azurdia's profile →
Citations per field
00.5×11.8×
Richard Azurdia · 1×
Citations per year

Countries citing papers authored by Yaqian Shi

Since Specialization
Citations

This map shows the geographic impact of Yaqian Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaqian Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaqian Shi more than expected).

Fields of papers citing papers by Yaqian Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaqian Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaqian Shi. The network helps show where Yaqian Shi may publish in the future.

Co-authorship network of co-authors of Yaqian Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yaqian Shi. A scholar is included among the top collaborators of Yaqian Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaqian Shi. Yaqian Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 1
5 2
6 3
7 1
8 6
9 20
10 12
11 5
12 7
13 12
14 7
15 23
16 11
17 32
18 14
19 33
20 0

About Yaqian Shi

Yaqian Shi is a scholar working on Dermatology, Pathology and Forensic Medicine and Cell Biology, having authored 28 papers that have together received 274 indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (15 papers), Dermatologic Treatments and Research (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). The work is most often cited by research in Dermatology (74 citations), Pathology and Forensic Medicine (87 citations) and Cell Biology (67 citations). Yaqian Shi has collaborated with scholars based in China, Japan and Canada. Frequent co-authors include Rong Xiao, Zhuotong Zeng, Yangfan Xiao, Rui Tang, Qiancheng Deng, Yaoyao Wang, Takuro Kanekura, Xinyu Ma, Xiangning Qiu and Weiping Xiong. Their work appears in journals such as Food Chemistry, Environmental Pollution and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026